✦ LIBER ✦

Chemotherapy with 5-fluorouracil (5-FU) and cisplatin or 5-FU, cisplatin, and vinblastine for advanced non-small cell lung cancer. A randomized phase II study of the cancer and leukemia group B

✍ Scribed by Frederick Richards Ii; David J. Perry; Maria Goutsou; Caron Modeas; Elaine Muchmore; Mark R. Green; Vishram Rege; A. Philippe Chahinian; Vera Hirsh; Bernard Poiesz

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 569 KB
Volume: 67
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19910615)67:12<2974::aid-cncr2820671206>3.0.co;2-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of etoposide and cisplati

Phase II trial of etoposide and cisplatin for refractory small cell lung cancer: A cancer and leukemia group B study

✍ Graziano, Stephen L. ;Lee, Kewchang ;Propert, Kathleen J. ;Tinsley, Roger ;Hayes 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB 👁 1 views

## Abstract A phase II trial of etoposide and cisplatin for patients with previously treated small cell lung cancer was carried out by CALGB from June 1983 to May 1984. Thirty‐five evaluable patients who had failed one prior chemotherapy regimen were treated with etoposide 80 mg/m^2^ and cisplatin

A phase I trial of ifosfamide, mesna, an

A phase I trial of ifosfamide, mesna, and cisplatin in advanced non-small cell lung cancer a cancer and leukemia group B study

✍ Stephen L. Graziano; James E. Herndon II; Frederick Richards II; Santo Difino; C 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 737 KB

Continuous-infusion cisplatin, 5-fluorou

Continuous-infusion cisplatin, 5-fluorouracil, and bolus methotrexate in the treatment of advanced non-small cell lung cancer

✍ Thomas J. Lynch Jr.; John R. Clark; Leslie A. Kalish; Barbara G. Fallon; Anthony 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 531 KB

Dihydro-5-azacytidine and cisplatin in t

Dihydro-5-azacytidine and cisplatin in the treatment of malignant mesothelioma : A phase II study by the Cancer and Leukemia Group B

✍ Brian L. Samuels; James Herndon II; David C. Harmon; Robert Carey; Joseph Aisner 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 3 views

## BACKGROUND. In a prior Cancer and Leukemia Group B (CALGB) Phase II trial of

Gemcitabine, ifosfamide, cisplatin (GIP)

Gemcitabine, ifosfamide, cisplatin (GIP) for the treatment of advanced non-small cell lung cancer: A phase II study of the Italian oncology group for clinical research (goirc)

✍ C. Boni; G. Bisagni; L. Savoldi; G. Moretti; E. Rondini; M. Sassi; A. Zadro; T. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 55 KB 👁 2 views

A randomized study of two vindesine plus

A randomized study of two vindesine plus cisplatin-containing regimens with the addition of mitomycin C or ifosfamide in patients with advanced non-small cell lung cancer

✍ R. Rosell; A. Abad-Esteve; I. Moreno; A. Barnadas; J. Carles; C. Fernandez; N. R 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 726 KB